Accretion Pharmaceuticals Limited (NSE:ACCPL)
108.00
-1.40 (-1.28%)
At close: May 6, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.2 billion as of May 6, 2026.
Market Cap
1.20B
Enterprise Value
1.28B
Revenue
826.43M
Ranking
n/a
PE Ratio
10.99
Stock Price
108.00
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.20B, an increase of 30.20%. That is a compound annual growth rate of 31.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.20B | 22.94% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aayush Wellness | 1.78B |
| Astonea Labs | 1.70B |
| Coral Laboratories | 1.51B |
| Lactose (India) | 1.50B |
| Bilcare | 1.46B |
| Bal Pharma | 1.20B |
| Concord Drugs | 1.11B |
| Denis Chem Lab | 1.07B |